XML 45 R29.htm IDEA: XBRL DOCUMENT v3.26.1
Organization and Basis of Presentation (Tables)
 3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Components of Marketable Securities
As of March 31, 2026 and December 31, 2025, marketable securities consisted of the following ($ in thousands):
 March 31, 2026
 Amortized CostGross
Unrealized Gain (loss)		Carrying Value
Equity securities:
Common stock, preferred stock and stock funds$48,158 $19,704 $67,862 
Available for sale debt securities:
U.S. Treasury and agency securities12,230 (1)12,229 
Certificates of deposit5,041 — 5,041 
Corporate debt securities10,933 (25)10,908 
Municipal debt securities475 6 481 
Total - Marketable securities $76,837 $19,684 $96,521 

 December 31, 2025
 Amortized CostGross
Unrealized Gain		Carrying Value
Equity securities:
Investment funds - debt securities$2,677 $6 $2,683 
Common stock, preferred stock and stock funds48,738 21,736 70,474 
Available for sale debt securities:
U.S. Treasury and agency securities10,186 103 10,289 
Certificates of deposit5,000 — 5,000 
Corporate debt securities8,954 105 9,059 
Municipal debt securities556 9 565 
Total - Marketable securities $76,111 $21,959 $98,070 
Schedule of Changes in Accumulated Other Comprehensive Income, Net by Component
Changes in Accumulated Other Comprehensive Income, Net by Component

Essex Property Trust, Inc.
($ in thousands):
 Change in fair value of derivatives and amortization of swap settlementsUnrealized
gain (loss) on
available for sale debt securities		Total
Balance at December 31, 2025$5,837 $210 $6,047 
Other comprehensive loss before reclassification(566)(216)(782)
Amounts reclassified from accumulated other comprehensive income 912 (13)899 
Other comprehensive income (loss)346 (229)117 
Balance at March 31, 2026$6,183 $(19)$6,164 

Essex Portfolio, L.P.
($ in thousands):
 Change in fair value of derivatives and amortization of swap settlementsUnrealized
gain (loss) on
available for sale debt securities		Total
Balance at December 31, 2025$9,921 $217 $10,138 
Other comprehensive loss before reclassification(586)(224)(810)
Amounts reclassified from accumulated other comprehensive income944 (13)931 
Other comprehensive income (loss)358 (237)121 
Balance at March 31, 2026$10,279 $(20)$10,259 
Schedule of Changes in the Redemption Value of Noncontrolling Interests
The changes in the redemption value of redeemable noncontrolling interests for the three months ended March 31, 2026 was as follows ($ in thousands):
Balance at December 31, 2025$28,263 
Reclassification due to change in redemption value and other1,898 
Redemptions(4,373)
Balance at March 31, 2026$25,788 
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows ($ in thousands):
 March 31, 2026December 31, 2025March 31, 2025December 31, 2024
Cash and cash equivalents - unrestricted$38,005 $76,241 $98,735 $66,795 
Cash and cash equivalents - restricted9,405 9,345 9,127 9,051 
Total unrestricted and restricted cash and cash equivalents shown in the condensed consolidated statements of cash flows$47,410 $85,586 $107,862 $75,846 
Schedule of Restricted Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows ($ in thousands):
 March 31, 2026December 31, 2025March 31, 2025December 31, 2024
Cash and cash equivalents - unrestricted$38,005 $76,241 $98,735 $66,795 
Cash and cash equivalents - restricted9,405 9,345 9,127 9,051 
Total unrestricted and restricted cash and cash equivalents shown in the condensed consolidated statements of cash flows$47,410 $85,586 $107,862 $75,846